Hammerhead ribozyme-mediated cleavage of the fusion transcript NPM-ALK associated with anaplastic large-cell lymphoma

By Hubinger G.   Wehnes E.   Xue L.   Morris S.W.   Maurer U.  

Experimental Hematology, Vol. 31, Iss. 3, 2003-03 ,pp. : 226-233

Elsevier

Access to resources Recommend Favorite

Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature

By Grewal Jaspreet   Smith Lauren   Winegarden Jerome   Krauss John   Tworek Joseph   Schnitzer Bertram  

Annals of Hematology, Vol. 86, Iss. 7, 2007-07 ,pp. : 499-508

Springer Publishing Company

Access to resources Recommend Favorite

Anaplastic large-cell non-Hodgkin’s lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer—a case report

By Fritzsche Florian   Pahl Stefan   Petersen Iver   Burkhardt Mick   Dankof Anja   Dietel Manfred   Kristiansen Glen  

Virchows Archiv, Vol. 449, Iss. 5, 2006-11 ,pp. : 561-564

Springer Publishing Company

Access to resources Recommend Favorite

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation - anti-CD40 monoclonal antibody induces rapid dephosphorylation and phos

By Hubinger G.   Scheffrahn I.   Muller E.   Bai R.   Duyster J.   Morris S.W.   Schrezenmeier H.   Bergmann L.  

Experimental Hematology, Vol. 27, Iss. 12, 1999-12 ,pp. : 1796-1805

Elsevier

Access to resources Recommend Favorite

Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein

By Ergin M.   Denning M.F.   Izban K.F.   Amin H.M.   Martinez R.L.   Saeed S.   Alkan S.  

Experimental Hematology, Vol. 29, Iss. 9, 2001-09 ,pp. : 1082-1090

Elsevier

Access to resources Recommend Favorite